Bernard Tobin, President Crescendo Bio Science at MYRIAD GENETICS INC (MYGN), sold 11,712 shares at $40.00 ($468K) on 2019-08-01, disclosed to the SEC on 2019-08-02.
Open-market sale of $468k MYGN by President Crescendo Bio Science. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.